Article Details

Sunesis Pharmaceuticals (NASDAQ:SNSS) Stock Rating Lowered by Wells Fargo & Company

Retrieved on: 2017-12-15 01:03:45

Tags for this article:

Click the tags to see associated articles and topics

Sunesis Pharmaceuticals (NASDAQ:SNSS) Stock Rating Lowered by Wells Fargo & Company. View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC raised its holdings in Sunesis Pharmaceuticals by 1.1% in the first quarter. <b>Renaissance Technologies</b> LLC now owns 111,811 shares of the biopharmaceutical company's stock worth $458,000 after purchasing an additional 1,230 shares during the period. Sphera Funds ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up